BillionDollarBreaks Archive - BillionDollarClub

TuesdayOct 27, 2026 9:00 am

BillionDollarBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Secures Conditional A$180 Million Financing Commitments for Donald Rare Earth Project

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising. Energy Fuels (NYSE American: UUUU) (TSX: EFR), a U.S.-based producer of rare earth elements, uranium and other critical materials, announced that Export Finance Australia ("EFA") and the National Reconstruction Fund Corporation ("NRFC") have conditionally approved commitments totaling up to A$180 million (US$126 million) toward a proposed A$200 million senior debt facility for Phase 1 construction of the Donald Rare Earth and Mineral Sands Project in Victoria, Australia. The proposed financing includes up to A$70 million from EFA, A$110 million from NRFC and A$20 million…

TuesdayOct 13, 2026 9:30 am

BillionDollarBreaks – Uranium Energy Corp. (NYSE American: UEC) Appoints Four National Security Leaders to Advisory Council

Uranium Energy (NYSE American: UEC) announced the appointment of former National Nuclear Security Administration (NNSA) Administrator Tom D'Agostino, retired Adm. James F. Caldwell, retired Adm. William K. Lescher and former NNSA Acting Administrator Neile Miller to its National Security Advisory Council. D'Agostino and Caldwell will serve as co-chairs. The appointments support the company's expansion into uranium conversion through its subsidiary, United States Uranium Refining & Conversion Corp., as it works to establish a domestic nuclear fuel supply chain serving U.S. defense and energy needs. The council brings together two former Navy admirals and two former NNSA leaders with extensive experience…

TuesdayOct 13, 2026 9:10 am

BillionDollarBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, presented its first in vivo proof-of-concept data and additional in vitro findings validating its BiTAC-ADC technology platform at the 17th World ADC Congress in San Diego. The in vivo study demonstrated significant tumor regression in a breast cancer model following a single 3 mg/kg dose, with no observed decrease in body weight. The results also showed that both BiTAC-ADC components were required to produce the intended tumor-specific response. Additional in vitro studies demonstrated the platform's ability to distinguish cancer cells from healthy cells, prevent the release of active…

WednesdayOct 07, 2026 12:00 pm

BillionDollarBreaks – Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) to Release Third-Quarter 2026 Results on Nov. 5

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising. Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) announced that it will release its third-quarter 2026 financial results on Nov. 5, after market close. The company will host a conference call on Nov. 6 at 11 a.m. ET to discuss the results. Investors can participate via a live webcast or by calling 1-800-715-9871 and entering conference ID 7288291. An accompanying slideshow will be available on the company's website before the call. A recording of the conference call will be accessible through Nov. 13, while…

MondayOct 05, 2026 12:45 pm

BillionDollarBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Shareholders Approve All Matters at Annual General and Special Meeting

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced that shareholders approved all matters submitted for a vote at its annual general and special meeting, including the election of six directors, amendments to the company Articles and amendments to its share-based compensation plan. A total of 123,182,474 common shares, representing 55.69% of votes attached to outstanding shares as of the record date, were represented at the meeting. Shareholders approved amendments to the Articles intended to align the company constating documents with listing rules of The Stock…

FridayOct 02, 2026 10:50 am

BillionDollarBreaks – D-Wave Launches Gate-Model Simulator Beta Program, Advancing Error-Aware Programming Capabilities

D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, recently launched its gate-model quantum computing simulator beta program, marking an important milestone in D-Wave’s gate-model development roadmap. The beta program offers select customers early access to the simulator in advance of its general availability to experiment with error-aware programming and develop quantum applications in preparation for D-Wave’s forthcoming gate-model systems. The simulator is built around D-Wave’s dual-rail superconducting gate-model technology, which is designed to harness error detection to deliver efficient quantum error correction with significantly…

ThursdaySep 17, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline

VERAXA has appointed Raju Willener as Chief Financial Officer, effective immediately. Willener brings more than 30 years of international experience spanning investment banking, corporate finance, asset management and capital markets. His appointment comes as VERAXA advances its proprietary BiTAC platform and a pipeline centered on antibody-drug conjugates and T-cell engagers. VERAXA has reported encouraging early data for its BiTAC technologies, including an in-vitro proof of concept for its BiTAC-ADC platform. VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has appointed Raju Willener as chief financial officer, adding a finance executive with more than three decades of…

FridaySep 11, 2026 3:05 pm

BillionDollarBreaks – D-Wave Quantum Inc. (NASDAQ: QBTS) Finalizes Definitive Agreement with U.S. Department of Commerce for up to $100 Million to Accelerate U.S. Leadership in Quantum Computing

D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, announced the execution of a definitive agreement with the U.S. Department of Commerce based on the previously announced Letter of Intent. D-Wave now has access to up to $100 million of U.S. CHIPS and Science Act funding. “We’re grateful to the U.S. government for this award to D-Wave and for the leadership it is demonstrating in advancing quantum innovation,” said Dr. Alan Baratz, CEO of D-Wave. “The Administration has made clear that U.S. quantum leadership will…

WednesdaySep 09, 2026 9:00 am

BillionDollarBreaks – BOXABL Inc. (NASDAQ: BXBL) Highlights Nationwide Portfolio of Modular Housing Deployments

BOXABL (NASDAQ: BXBL) an innovative technology company transforming the housing market with its modular building systems, highlighted a portfolio of completed and in-progress projects demonstrating deployments of its factory-built housing system nationwide. Projects include a permanent 12-unit park-model RV Casita installation at American Campground in Las Vegas, wildfire relief support in Pasadena, California, a 12-unit stacked Casita project for Catholic Charities in Oklahoma City and the 12-unit Pasadera short-term rental community near Oklahoma State University. BOXABL is also working with Horizons Getaways on a network of eco-luxury cabin resorts across multiple states, with 10 units already delivered to locations in…

FridaySep 04, 2026 9:00 am

BillionDollarBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer

VERAXA Biotech (NASDAQ: VRXA) a developer of next-generation antibody-based cancer therapies, announced the appointment of Raju Willener as chief financial officer, effective immediately. Willener brings more than three decades of international financial leadership experience spanning global capital markets, investment banking, corporate finance, asset management and strategic leadership. He will report to CEO and Co-Founder Christoph Antz, Ph.D., and is expected to support the company’s capital strategy, strategic opportunities and continued development of its proprietary BiTAC(R) technology platform and oncology pipeline. Prior to joining VERAXA, Willener served as director of corporate development at Exentis Group AG before being appointed CFO in…

The exclusive home of the biggest and brightest companies covered by IBN.

Contact us: (512) 354-7000

GreenEnergyNewsBreaks